The Rett Syndrome Research Trust (RSRT) is teaming up with partners in industry and academia to get ready for…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The first girl with Rett syndrome has been given the experimental gene therapy TSHA-102 in a clinical trial, according…
Treatment with Anavex 2-73 (blarcamesine) led to improvements in behavior among children with Rett syndrome in a Phase 2/3…
Rett syndrome is marked by unusually low levels of LAT1, a protein that’s needed to move amino acids —…
Electrically stimulating a specific region of the brain led to improvements in memory in a mouse model of Rett…
Treatment with a modified version of a signaling molecule called NGF improved survival and normalized behavior in a mouse model…
A second adult with Rett syndrome has been given the experimental gene therapy TSHA-102 in an ongoing clinical trial,…
Girls with Rett syndrome have detectable abnormalities in the electrical activity in their brains, a new study confirms. The…
Repetitive movements of rubbing the hands together are associated with an increased risk of skin injuries in people with…
The first woman with Rett syndrome given the gene therapy TSHA-102 has experienced improvements in her sleep, breathing, and…